SCHEMBL3928795

SCHEMBL3928795

COc1ccc(Br)c(CC=O)c1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.41
HTR2A P28223 2/20 0.40
HTR2C P28335 2/20 0.40
HTR1A P08908 5/20 0.40
SLC6A4 P31645 5/20 0.40
HSD17B10 Q99714 1/20 0.40
CHRM2 P08172 1/20 0.40
CHRM1 P11229 1/20 0.40
CHRM3 P20309 1/20 0.40
ERN1 O75460 1/20 0.40
TRIM24 O15164 1/20 0.40
TYR P14679 1/20 0.40
TRIM33 Q9UPN9 1/20 0.40
APLNR P35414 1/20 0.40
ADRA1A P35348 1/20 0.39
TAAR1 Q96RJ0 1/20 0.39
IDO1 P14902 1/20 0.39
HPGD P15428 1/20 0.38
CYP2A6 P11509 1/20 0.38
HDAC1 Q13547 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2310172 0.87 APLNR (0.44) ALDH1A1HTR2AHTR2CHSD17B10CHRM2
SCHEMBL9349817 0.82 ALDH1A1 (0.52) ALDH1A1HTR1ASLC6A4ADRA1ATAAR1
SCHEMBL2001551 0.81 HSD17B10 (0.44) HTR2AHTR2CHTR1ASLC6A4HSD17B10
SCHEMBL15602182 0.80 CA12 (0.41) ALDH1A1HSD17B10
SCHEMBL7749412 0.80 CA12 (0.41) HTR1AHSD17B10ERN1
SCHEMBL885029 0.80 HSD17B10 (0.57) ALDH1A1HTR2AHSD17B10APLNRADRA1A
SCHEMBL30229484 0.80 HSD17B10 (0.57) ALDH1A1HTR2AHSD17B10APLNRADRA1A
SCHEMBL7668586 0.79 HSD17B10 (0.43) HTR2AHTR2CHTR1ASLC6A4HSD17B10
SCHEMBL7551792 0.79 ADRA1A (0.48) HTR2AHTR2CHTR1ASLC6A4ADRA1A
SCHEMBL7144114 0.79 ALDH1A1 (0.41) ALDH1A1HTR2AHSD17B10CHRM2CHRM1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020208139-A1 INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS CELLESTIA BIOTECH AG (CH) 2020-10-15 WO disclosed
WO-2013022740-A2 GPR35 LIGANDS AND THE USES THEREOF CORNING INCORPORATED (US) 2013-02-14 WO disclosed
EP-2044083-A1 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. (US) 2009-04-08 EP disclosed
WO-2008008912-A1 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. (US) 2008-01-17 WO disclosed
WO-2008008907-A2 ANTIVIRAL AGENTS GENELABS TECHNOLOGIES, INC. (US) 2008-01-17 WO disclosed
WO-2007019397-A2 6-MEMBERED ARYL AND HETEROARYL DERIVATIVES FOR THE TREATMENT OF HEPATITIS C VIRUS GENELABS TECHNOLOGIES, INC. (US) 2007-02-15 WO disclosed
EP-1651631-A1 BICYCLIC IMIDAZOL DERIVATIVES AGAINST FLAVIVIRIDAE GENELABS TECHNOLOGIES, INC. (US) 2006-05-03 EP disclosed
WO-2005012288-A1 BICYCLIC IMIDAZOL DERIVATIVES AGAINST FLAVIVIRIDAE GENELABS TECHNOLOGIES, INC (US) 2005-02-10 WO disclosed